German-based firm Biotronik’s US division has commercially launched its MR conditional quadripolar (QP) cardiac resynchronisation therapy pacemaker (CRT-P), Edora HF-T QP, following approval from the US Food and Drug Administration (FDA).

Featuring MRI AutoDetect technology, 15cc volume, and longevity of approximately ten years, Edora HF-T QP is intended to minimise device replacement frequency for heart failure patients.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The MRI AutoDetect technology has been developed to enhance patient safety by decreasing the time in which the device is in MRI mode.

Once activated by a clinician, the technology automatically identifies an MRI field and changes the device programming to MRI mode.

Biotronik president Marlou Janssen said: “With the launch of Edora HF-T QP, Biotronik offers a full suite of ProMRI products, ensuring physicians can always choose MRI conditional devices for their patients.

"Our devices are the only FDA-approved CRM solutions that provide automatic detection of an MRI environment, physiologic rate adaptation, and automatic daily remote monitoring."

“Our devices are the only FDA-approved CRM solutions that provide automatic detection of an MRI environment, physiologic rate adaptation, and automatic daily remote monitoring.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The pacemaker also includes closed loop stimulation (CLS) and Biotronik Home Monitoring, which is a cardiac device remote monitoring system that comes with automatic, daily transmission verification.

The system features a summary of nine long-term heart failure statistics called Heart Failure Monitor that, in combination with daily updates, enables continuous monitoring and assessment of heart failure status.

According to previous studies, the system is linked to 50% decrease in mortality by heart failure and 36% decrease in hospitalisation for worsening heart failure.

Image: Biotronik Edora 8 HF-T QP. Photo: courtesy of Biotronik.